[ Price : $8.95]
Magellan Diagnostics recalls its LeadCare II, LeadCare Plus, and LeadCare Ultra blood lead tests due to concerns about false low r...[ Price : $8.95]
A panel of FDA staff from CDER and the Office of Regulatory Affairs provide the latest insights into common data integrity inspect...[ Price : $8.95]
FDA warns Condemned Labz that it is marketing misbranded unapproved new drugs.[ Price : $8.95]
PhRMA tells FDA it appreciates many of the revisions the agency has made to a draft guidance on sponsor responsibilities for safet...[ Price : $8.95]
FDA grants priority review to ViiVs cabotegravir to prevent acquisition of HIV in certain men.[ Price : $8.95]
The Justice Department says Affordable Healthcare Solutions pled guilty to one felony count of receiving adulterated medical devic...[ Price : $8.95]
FDA accepts for review a Regeneron Pharmaceuticals supplemental BLA for PD-1 inhibitor Libtayo (cemiplimab-rwlc) to treat certain ...[ Price : $8.95]
Eisai begins a rolling BLA submission for lecanemab, the companys investigational anti-amyloid beta protofibril antibody for treat...